Advertisement · 728 × 90
#
Hashtag
#AFSymposium2026
Advertisement · 728 × 90
Post image

Next-gen Amulet 360 #LAAO showed favorable early outcomes in the VERITAS study. Both primary endpoints were met, and key clinical outcome rates were low. No leak was observed in 93.9% of patients on the 45-day TEE. https://bit.ly/4a1rS10

#JACCCEP #AFib #CardioSky #AFSymposium2026

0 0 0 1
Post image

ADVANTAGE AF subanalysis: Linear bipolar PFA for CTI shows safety and efficacy comparable to RF, with greater efficiency, and supports a standardized coronary safety protocol.

Details in #JACC: https://bit.ly/4rm47al #AFSymposium2026 #AFib #CardioSky

0 0 0 0
Dr. Devi Nair at AF SYmposium 2026

Dr. Devi Nair at AF SYmposium 2026

Boston Scientific & Siemens Healthineers

Boston Scientific & Siemens Healthineers

Today at #AFSymposium2026, Dr. Devi Nair shared her first clinical experience using the next-generation ACUNAV Luxera 4D ICE Catheter* in a WATCHMAN™ LAAC case. Developed in close collaboration with Siemens Healthineers, we're excited to continue advancing ICE imaging for WATCHMAN™ LAAC procedures.

0 0 1 0
Graphic announcing LAAC case at AF Symposium

Graphic announcing LAAC case at AF Symposium

Don't miss at #AFSymposium2026: Dr. Devi Nair will present her experience with a next-generation 4D ICE catheter used in a WATCHMAN FLX™Pro #LAAC case.
📆Friday, February 6
⌚10AM - 12:30PM
WATCHMAN FLX Pro Left Atrial Appendage Closure Device Indications, Safety, & Warnings: qrco.de/bg3esL

0 0 1 0
AF Symposium 2026, Late-breaking FARAPULSE PFA Platform Clinical Data

AF Symposium 2026, Late-breaking FARAPULSE PFA Platform Clinical Data

📊Catch these Late-Breaking Clinical Science Sessions and other key FARAPULSE™ PFA Platform data releases at #AFSymposium2026 this weekend!

View the full program here: qrco.de/bgatmg

0 0 0 0
See you at AF Symposium 2026!

See you at AF Symposium 2026!

We’re heading to #AFSymposium2026 this weekend! Will we see you there?

Explore our comprehensive electrophysiology portfolio, dive into clinical evidence, and see our vision for future innovation – all in the name of advancing patient outcomes. We’re looking forward to connecting with you!

0 0 0 0